Sensory satellite glial Gq-GPCR activation alleviates inflammatory pain via peripheral adenosine 1 receptor activation

Sci Rep. 2020 Aug 25;10(1):14181. doi: 10.1038/s41598-020-71073-z.

Abstract

Glial fibrillary acidic protein expressing (GFAP+) glia modulate nociceptive neuronal activity in both the peripheral nervous system (PNS) and the central nervous system (CNS). Resident GFAP+ glia in dorsal root ganglia (DRG) known as satellite glial cells (SGCs) potentiate neuronal activity by releasing pro-inflammatory cytokines and neuroactive compounds. In this study, we tested the hypothesis that SGC Gq-coupled receptor (Gq-GPCR) signaling modulates pain sensitivity in vivo using Gfap-hM3Dq mice. Complete Freund's adjuvant (CFA) was used to induce inflammatory pain, and mechanical sensitivity and thermal sensitivity were used to assess the neuromodulatory effect of glial Gq-GPCR activation in awake mice. Pharmacogenetic activation of Gq-GPCR signaling in sensory SGCs decreased heat-induced nociceptive responses and reversed inflammation-induced mechanical allodynia via peripheral adenosine A1 receptor activation. These data reveal a previously unexplored role of sensory SGCs in decreasing afferent excitability. The identified molecular mechanism underlying the analgesic role of SGCs offers new approaches for reversing peripheral nociceptive sensitization.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzilates / pharmacology
  • Clozapine / analogs & derivatives
  • Clozapine / pharmacology
  • Freund's Adjuvant / toxicity
  • GTP-Binding Protein alpha Subunits, Gq-G11 / physiology*
  • Genes, Synthetic
  • Hot Temperature
  • Hyperalgesia / physiopathology
  • Hyperalgesia / prevention & control*
  • Inflammation / chemically induced
  • Inflammation / physiopathology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Muscarinic Agonists / pharmacology
  • Neuroglia / enzymology*
  • Neuroglia / physiology
  • Nociception / physiology*
  • Nortropanes / pharmacology
  • Promoter Regions, Genetic
  • Purinergic P1 Receptor Agonists / pharmacology
  • Purinergic P1 Receptor Antagonists / pharmacology
  • Receptor, Adenosine A1 / drug effects
  • Receptor, Adenosine A1 / physiology*
  • Receptor, Muscarinic M3 / drug effects
  • Receptor, Muscarinic M3 / genetics
  • Receptor, Muscarinic M3 / physiology*
  • Receptors, G-Protein-Coupled
  • Recombinant Fusion Proteins / drug effects
  • Recombinant Fusion Proteins / metabolism
  • Theophylline / analogs & derivatives
  • Theophylline / pharmacology
  • Touch
  • Xanthines / pharmacology

Substances

  • Benzilates
  • Muscarinic Agonists
  • Nortropanes
  • Purinergic P1 Receptor Agonists
  • Purinergic P1 Receptor Antagonists
  • Receptor, Adenosine A1
  • Receptor, Muscarinic M3
  • Receptors, G-Protein-Coupled
  • Recombinant Fusion Proteins
  • Xanthines
  • 8-(3-sulfophenyl)theophylline
  • trospium chloride
  • Freund's Adjuvant
  • 1,3-dipropyl-8-cyclopentylxanthine
  • Theophylline
  • GTP-Binding Protein alpha Subunits, Gq-G11
  • Clozapine
  • clozapine N-oxide